4-(Hydroxymethyl)benzoic acid,
3006-96-0,
4-HYDROXYMETHYLBENZOIC ACID,
4-Hydroxythylbenzoic acid,
HMBA Linker,
96937-45-0,
UNII-9Z28L8STHD,
4-(hydroxymethyl)-benzoic acid,
Benzoic acid, 4-(hydroxymethyl)-,
MFCD00017598,
4-(Hydroxymethyl)benzoicacid,
9Z28L8STHD,
Benzoic acid, 4-hydroxymethyl-,
4-carboxybenzyl alcohol,
4-Hydroxymethylbenzoic acid, 98%,
HMBA Linker;,
Enamine_005867,
PubChem12790,
ACMC-1CKJC,
AC1L2QQT,
AC1Q5TWL,
p-Hydroxymethylbenzoic Acid,
AC1Q7C0B,
p-hydroxymethyl benzoic acid,
4-hydroxymethyl-benzoic acid,
SCHEMBL49984,
Eprosartan related compound E,
KSC176Q7R,
4-(Hydroxylmethyl)benzoic acid,
Jsp005686,
DTXSID40184111,
WWYFPDXEIFBNKE-UHFFFAOYSA-N,
HMS1410K15,
ZINC135484,
ACN-S003439,
ALBB-029043,
ANW-26763,
CCG-49783,
CH-232,
RB3326,
SBB052730,
4-(Hydroxymethyl)benzoic acid, 99%,
AKOS001053879,
AC-3060,
CS-W018100,
EBD3073250,
MCULE-9885454652,
RP21570,
RTR-004583,
TRA0044729,
IDI1_008102,
KS-000008W8,
58590-49-1,
AJ-12269,
AK-25734,
AN-13375,
BC215027,
BR-25734,
Q230,
SC-23127,
SY003712,
TS-02011,
AB0017465,
DB-013127,
ST2411010,
AM20050236,
FT-0618719,
FT-0695624,
ST50824323,
M-3165,
M02899,
MFCD00017598 (97+%),
006H960,
I01-3587,
J-513746,
SR-01000639214-1,
Ecamsule Related Compound B, United States Pharmacopeia (USP) Reference Standard,
Eprosartan Related Compound E, United States Pharmacopeia (USP) Reference Standard,
HMBA; RARECHEM AL BO 1443; 4-CARBOXYBENZYL ALCOHOL; 4-HYDROXYMETHYLBENZOIC ACID-OH),
4AY,
HMP linker,
4- BENZOICACID,
Ecamsule Related Compound B,
C8H8O3,
P-HYDROXYMETHYLBENZOICACID,
4-HYDROXYMETHYLBENZOICACID,
4-(BROMOMETHYL)BENZOIC ACID,
C8-H8-O3,
CID76360,
CS-CY-00024,
AR-1F7055,
4-Hydroxymethyl-cyclohexanecarboxylic acid,
A7041,
H0769,
4-Hydroxymethylbenzoic acid, 98% - 100G 100g,
13380-84-2,
1020353-46-1,
30925-07-6,
68858-21-9,